Lisi L - Search Results

1

DNA inhibitors for the treatment of brain tumors.

Lisi L, Chiavari M, Ciotti GMP, Lacal PM, Navarra P, Graziani G. Lisi L, et al. Expert Opin Drug Metab Toxicol. 2020 Mar;16(3):195-207. doi: 10.1080/17425255.2020.1729352. Epub 2020 Feb 26. Expert Opin Drug Metab Toxicol. 2020. PMID: 32067518 Review.

2

Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial.

Choy EH, Hazleman B, Smith M, Moss K, Lisi L, Scott DG, Patel J, Sopwith M, Isenberg DA. Choy EH, et al. Among authors: lisi l. Rheumatology (Oxford). 2002 Oct;41(10):1133-7. doi: 10.1093/rheumatology/41.10.1133. Rheumatology (Oxford). 2002. PMID: 12364632 Clinical Trial.

3

Erythropoietin inhibits basal and stimulated corticotropin-releasing hormone release from the rat hypothalamus via a nontranscriptional mechanism.

Tringali G, Pozzoli G, Lisi L, Navarra P. Tringali G, et al. Among authors: lisi l. Endocrinology. 2007 Oct;148(10):4711-5. doi: 10.1210/en.2007-0431. Epub 2007 Jul 5. Endocrinology. 2007. PMID: 17615151

4

The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm.

Tringali G, Lisi L, Bettella F, Renier D, Di Stasi SM, Navarra P. Tringali G, et al. Among authors: lisi l. Pharmacol Res. 2008 Nov-Dec;58(5-6):340-3. doi: 10.1016/j.phrs.2008.09.008. Epub 2008 Sep 18. Pharmacol Res. 2008. PMID: 18848989

5

Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain.

Tringali G, Lisi L, De Simone ML, Aubry JM, Preziosi P, Pozzoli G, Navarra P. Tringali G, et al. Among authors: lisi l. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 31;33(6):1017-21. doi: 10.1016/j.pnpbp.2009.05.012. Epub 2009 May 23. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19467289

6

Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes.

Dello Russo C, Lisi L, Navarra P, Tringali G. Dello Russo C, et al. Among authors: lisi l. J Neuroimmunol. 2009 Aug 18;213(1-2):78-83. doi: 10.1016/j.jneuroim.2009.05.016. Epub 2009 Jun 23. J Neuroimmunol. 2009. PMID: 19552966

7

Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation.

Dello Russo C, Lisi L, Tringali G, Navarra P. Dello Russo C, et al. Among authors: lisi l. Biochem Pharmacol. 2009 Nov 1;78(9):1242-51. doi: 10.1016/j.bcp.2009.06.097. Epub 2009 Jul 1. Biochem Pharmacol. 2009. PMID: 19576187 Free article.

8

Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology.

Capuano A, De Corato A, Lisi L, Tringali G, Navarra P, Dello Russo C. Capuano A, et al. Among authors: lisi l. Mol Pain. 2009 Aug 6;5:43. doi: 10.1186/1744-8069-5-43. Mol Pain. 2009. PMID: 19660121 Free PMC article.

9

The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.

Lisi L, Navarra P, Feinstein DL, Dello Russo C. Lisi L, et al. J Neuroinflammation. 2011 Jan 5;8(1):1. doi: 10.1186/1742-2094-8-1. J Neuroinflammation. 2011. PMID: 21208419 Free PMC article.

10

Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR.

Dello Russo C, Lisi L, Lofaro A, Di Giambenedetto S, Federico B, Madeddu G, Salerno M, Mura MS, Pirazzoli A, de Luca A, Cauda R, Navarra P. Dello Russo C, et al. Among authors: lisi l. Pharmacogenomics. 2011 Apr;12(4):567-76. doi: 10.2217/pgs.10.208. Pharmacogenomics. 2011. PMID: 21521028 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page